We previously reported that small interfering RNA (siRNA) enhances DNA or DNA virus mediatedinterferon (IFN)-λ1 induction through retinoic acid-inducible gene I (RIG-I) and interferon gammainducible protein 16 (IFI16) crosstalk-signalling pathway. Here we provide further evidence of a new role for siRNA. siRNA containing a 5-nucleotide (nt) motif sequence suppresses DNA-mediated IFNs and inflammatory cytokines. We determined that motif siRNA inhibits the induction when the motif is located at the 3' or 5'-terminus of siRNA. Using THP1-Lucia ISG cells with various DNA stimulants, it is demonstrated that motif siRNA inhibits DNA or DNA virus but not RNA virus-mediated signaling.
Introduction
Innate immunity is the first line of defense and relies on germ line-encoded pattern recognition receptors (PRRs) [1] . It has been known for over a decade that DNA, the most recognizable unit of life, is a potent trigger of inflammatory responses in cells [2] . A significant effort from many laboratories has highlighted the importance of cytosolic DNA sensing in the innate immune response against invading DNA focusing on the induction of type-I IFN, Interleukin (IL)-1β or IL-18 [3] . For example, DEAD-box helicase 41 (DDX41) [4] , Gamma-interferon-inducible protein (IFI16) [5] and DNA-dependent activator of IFN-regulatory factors (DAI) [6] detect double stranded DNAs (dsDNAs) and activate the STING-TBK1-IRF3 (stimulator of interferon genes -tank-binding kinase 1 -interferon regulatory factor 3) pathway. Leucine-rich repeat flightless-interacting protein 1 (LRRFIP1) binds dsDNA and triggers IRF3 activation through β-catenin [7] . DEAH box protein (DHX)9 and DHX36 associate with dsDNA and lead to NFκB activation through Myeloid Differentiation Primary Response 88 (MyD88) [8, 9] . Cyclic GMP-AMP Synthase (cGAS) has been most recently defined a well-known DNA sensor that recognizes cytoplasmic DNA [10, 11] . Once detect DNA, cGAS undergoes a conformational change that allows ATP and GTP to come into the catalytic pocket, leading to the synthesis of cGAMP, a strong activator of the STING-TBK1 axis [10, 11] . Absent in melanoma 2 (AIM2), a PYHIN (Pyrin-and HIN200-domain-containing) protein, interacts with cytosolic DNA and activates inflammasomes by recruiting apoptosis-associated speck-Like protein (ASC) and procaspase-1 and subsequently mature forms of IL-1β and IL-18 were produced [12] [13] [14] . Immune responses to DNA are not restricted to type I IFN-inducing pathways: cytosolic DNA also activates type III IFNs [15] [16] [17] [18] [19] , IFN-λ1 [20] [21] [22] , IFN-λ2/3 [23, 24] and IFN-λ4 [25, 26] . In human cells, Ku70, a DNA repair protein, predominantly induces IFN-λ1 upon DNA transfection or DNA virus infection and this induction is associated with a translocation of Ku70 from the nucleus to the cytoplasm to bind dsDNA, interacts with STING and promotes production of type III IFNs through activation of IRF3, IRF1 and IRF7 [20, 27] . Of note, the mouse ifnl1 gene lacks exon 2 and contains a stop codon within exon 1, which results in the failure to encode a functional IFN-λ1 protein [16] . So, the study related to a physiological relevance of the induction of IFN-λ1 in a mouse model is not capable.
Investigation of the mechanism of the Innate immune activation by cytosolic DNA from microbial pathogens has been extensively studied in terms of both DNA binding proteins and the mechanism of DNA recognition for subsequent downstream signaling and immune activation [28, 29] . However, in some scenarios, those cascade inductions of cytokines or inflammatory chemokines maybe harmful for the host cells, some diseases are highly related with those over-responses of innate immunities [30] . Some reagents must possess mechanisms to subvert the signaling pathway to establish successful regulation. However, this kind of study is rarely reported.
Small interfering RNAs (siRNAs) are artificially synthesized 19-23 nucleotide long double-stranded RNA molecules [31] . They are routinely used in molecular biology for a transient silencing of gene of interest. Except the biological function of specific gene knocking down by siRNA, other potential functions of siRNA are also reported. siRNAs were originally thought incapable of inducing immune responses because they are short and designed to mimic the natural product of Dicer in vivo.
However, many studies have reported innate immune stimulation by siRNA and/or the siRNA delivery vehicle [32] [33] [34] [35] . Various features of the siRNA structure, sequence, and delivery mode have contributed to the immune stimulation effect, leading to undesired effects and the misinterpretation of experimental results, for example the production of IFN-α, tumor necrosis factor alpha (TNF-α), IL-6
and IL-12 [32, [36] [37] [38] [39] . Previous studies indicated that transfection of siRNA could activate doublestranded RNA-activated protein kinase R (PKR) [40] or TLR3 [41] in a sequence-independent manner or sequence-dependently recognized by TLR7 in mice and TLR7/8 in humans [42] . And our recent study also consistently indicated that siRNA cooperated with invading DNA by DNA transfection or DNA virus infection, highly induces type III IFN response through RIG-1 and IFI16 crosstalk signaling pathway. This finding further shed light on the widely existed but uncovered functions of siRNA [21] .
Coincidence with our previous study, we reported here, another new function of siRNAs. Except for the RNA interference and innate immunostimulatory function of siRNA, we found siRNA containing a unique 5-nt motif at the 3' or 5' terminus of siRNA sense strand potently inhibits a DNA sensor, IFI16mediated innate immune response in response to DNA or DNA virus-derived intracellular stimulation.
The finding may provide a new strategy to regulate the over-response of the innate immune system for the host cells upon pathogen invasion, shedding light on a novel function of siRNA with the unique 5-nt motif as a quencher of the innate immunity and a potential therapeutic agent for auto immune diseases.
Results
The impact of different siRNA transfection on DNA-mediated IFNL1 induction.
We previously reported that siRNA enhances DNA transfection or DNA virus infection-mediated type III IFN response through a crosstalk between RIG-I (an RNA sensor) and IFI16 (a DNA sensor) signaling pathway [21] . In a course of study, to identify a mechanism of the siRNA-mediated IFNL1 induction in IFN-α-treated Hela cells, a total of 48 siRNAs including non-target siRNAs (Ctrl-siRNA, siRNA targeting GFP or luciferase) and siRNAs targeting IFN-stimulatory genes (ISGs) were transfected into the IFN-α-treated HeLa cells, and the cells were further stimulated by DNA transfection to induce DNA-mediated innate immune response. The cells were then collected 6 h after DNA transfection to detect IFNL1 mRNA expression level by real-time RT-PCR. The experimental procedure was presented in the Figure 1A . The results consistently showed that some siRNAs highly enhanced DNA-mediated IFNL1 induction, for example Ctrl-siRNA, siIFIT1-1, siTrim25, siIFIT5-2, siDENND2D-1, siDENND2D-2 and siPCGF1-1 ( Figure 1B & 1C) . The sequences of all the siRNAs to enhance DNA-mediated signaling were listed in the Table EV1 . Simultaneously, we were also noticed that some of two different siRNAs targeting same gene but encoding different seeding RNA sequence demonstrated a conflicting result, one siRNA enhanced or had no effect, and one inhibited the DNAinduced IFNL1 induction. They were siRNAs targeting IFIT1 (siIFIT1-1 and siIFIT1-2), siRNAs targeting TRIM22 (siTRIM22-1 and siTRIM22-2) and siRNAs targeting LOC732371 (siLOC732371-1 and siLOC732371-2). Their sequences of those three siRNAs which inhibited DNA-induced IFNL1 induction was listed in the Figure 1D . A Sequence analysis illustrated that one 5-nucleotide (nt) sequence 5'-AAGAA-3' was found in all three sense strands of siRNAs, we call it as 5-nt motif in our study.
Motif siRNA motif-location dependently affects DNA-mediated IFNL1 induction.
To assess whether this 5-nt motif sequence was responsible for suppressing the DNA-mediated IFNL1 induction, we used Ctrl-siRNA which highly enhances DNA-mediated IFN response as a control sequence [21] . Total 6 variants of siRNAs that encoded the motif sequence at different location in the RNA sequence were designed and chemically synthesized, as shown in the Figure 2A .
The original sequence of Ctrl-siRNA (wild type) was replaced with 5-nt motif sequence; the motif was located from the 5' terminus to 3' terminus of siRNA sense strand and was represented by 5'm-siRNA, 5'm1-siRNA, 5'm2-siRNA, mm-siRNA, 3'm1-siRNA and 3'm-siRNA respectively (Figure 2A ). And then following the same experimental method as shown in Figure 1A , those variants were transfected into HeLa cells, and followed by IFN-α treatment on day 2 and DNA transfection on day 3. The cells were subjected by total cellular RNA extraction at 6 h or 24 h after DNA transfection, and the levels of IFNL1 mRNA expression were measured by real time RT-PCR ( Figure 2B ). The results showed that the impact of 6 motif siRNAs on IFNL1 induction was different. Variants with the motif either at 3' terminus or 5' terminus (5'm-siRNA and 3'm-siRNA) showed no effect on the IFN induction compared with the cells without siRNA transfection. And the variant with the motif in the middle (mm-siRNA) indicated a strong enhancement for the IFN induction as does Ctrl-siRNA. Collectively, the impact of motif siRNA on the DNA-mediated IFN induction was shown a bell-shaped response along with changes of the motif location from 5' terminus to the 3' terminus. and the results from the samples collected at 24 h after DNA transfection were consistent with that of 6 h time point. In summary, the motif siRNA affected DNA-mediated IFNL1 induction with a location dependent manner.
Motif siRNA potently suppresses Ctrl-siRNA-enhanced DNA-mediated IFNs and inflammatory cytokines.
To further clarify a role of the inhibitory effect of motif siRNA, different dose of 3'm-siRNA or mm-siRNA was co-transfected with 10 nM Ctrl-siRNA in HeLa cells, and then followed by IFN-α treatment on day 2 and DNA transfection on day 3. The IFNL1 mRNA expression level was measured by real time RT-PCR ( Figure 3A) . The results showed that 3'm-siRNA dose-dependently inhibited the Ctrl-siRNA/DNA-mediated IFNL1 induction, in contrast, the variant encoding the motif sequence in the middle (mm-siRNA) did not show the similar suppression. This result indicated that the 3'm-siRNA was able to compete Ctrl-siRNA-enhanced signal in the IFN-induction. To further define whether the 3'm-siRNA suppresses other cytokine induction, gene activation of IFNL2/3, IFNB, CXCL10, RANTES and TNFA were also analyzed. The results clearly indicated that co-transfection of 3'm-siRNA suppressed the Ctrl-siRNA/DNA-mediated cytokine inductions ( Figure 3B ). Therefore, motif siRNA with motif at an end location was able to inhibit the production of not only IFN but also inflammatory cytokines.
To further characterize a gene regulation profile in the cells transfected with the 3'm-siRNA, a microarray analysis was performed. Following the same experimental protocol, we transfected HeLa cells with 10 nM Ctrl-siRNA alone or 10 nM Ctrl-siRNA and 3'm-siRNA, and then harvested RNA at 6 h after DNA transfection. The gene expression was compared between presence and absence of 3'm-siRNA. From three independent experiments, we found that the expression of 113 genes was ≥1.5-fold greater with Ctrl-siRNA than with the combination of 3'm-siRNA and Ctrl-siRNA. Using gene ontology analyses (DAVID), we found that the set of 51 genes was significantly enriched for genes involved in biological processes such as innate immune response and inflammatory cytokines ( Figure   3C ). The details for those 51 genes were provided in the Table EV2 . This observation was consistent with the idea that motif siRNA with the motif at the 3' or 5' terminus suppressed the induction of genes involved in the interferon and inflammatory response. Several genes involved in apoptosis were also presented. These data confirm that motif siRNA with the motif at the 3' or 5' terminus specifically suppressed the induction of genes involved in innate immune responses and some cytokine induction pathways.
Exchange of any nucleotide of the motif sequence decreases the inhibitory efficacy of 3'm-

AAGAA siRNA
Through screening the impact of 48 siRNAs on IFN induction, we found that the motif 5'-AAGAA-3' existed in all siRNAs which inhibited DNA transfection-induced IFNL1 induction. And this motif must be located at the end terminus of the siRNA to make motif siRNA potently inhibited Ctrl-siRNA/DNAinduced interferon response and inflammatory cytokines. Those observations led us to speculate whether the 5-nt sequence is essential for motif siRNA to inhibit DNA-induced signaling. So, we further designed several motif siRNAs with one nucleotide change and compared the inhibitory effect among the variants. The designed mutants are listed in the Figure 4A . And then those motif siRNAs were transfected to HeLa cells with 10 nM Ctrl-siRNA to define whether the motif siRNA still inhibited Ctrl-siRNA/DNA-mediated IFNL1 induction. Compared with 3'm-AAGAA siRNA, all other motif siRNA with one nucleotide change, 3'm-AAAAA, 3'm-AAUAA, 3'm-AACAA, 3'm-ACGAA, 3'm-AAGUA and 3'm-AAGAU increased IFNL1 induction. The results indicated that the inhibitory activity of 5-nt AAGAA motif siRNA is depends on the sequence of the motif. We further confirmed here that the immunosuppressive motif sequence is 5'-AAGAA-3'.
Motif siRNA suppresses DNA or DNA virus-mediated innate immune response.
As the motif siRNA abolished DNA plasmid-mediated IFN induction, we also examined whether the motif siRNA inhibits other stimulants-induced innate immune response. This experiment was performed using a THP1-Lucia ISG cells. THP1-Lucia ISG cells were derived from the human monocytic cell line THP-1, which represents a model of choice to study the activation and signaling of Cytosolic DNA Sensors (CDS), and THP-1 cells have been shown to express all the CDS identified so far [4, 43, 44] , with the exception of DAI [6, 45] . Using this cells as a screening platform, we transfected 3'm-siRNA at a dose of 0, 10, 20 and 50 nM, and then the cells were stimulated by different stimulants for CDS, Plasmid DNA, poly(A:T), 2'3'-cGAMP, VACV-70 and HSV-60, Lucia luciferase in the cells was monitored as an indicator for immune response. the Ctrl-siRNA-enhanced DNA-mediated immune response was also included in this experiment as a positive control. The result demonstrated that all the tested stimulants initiated a certain level of luciferase activity, and the induction of Luciferase activity by all CDS agonists but 2'3'-cGAMP was decreased by a motif siRNAdose dependently manner ( Figure 5A ). Furthermore, we tested whether motif siRNA suppresses virus-mediated innate immune response in THP1 cells. the THP1 cells were first transfected by 3'm-siRNA at different doses. and then the cells were infected by a DNA virus, HSV-1 at a MOI of 5 ( Figure 5B 
Motif siRNA dose-dependently inhibits HSV-1 virus infection-mediated innate immune response in human primary immature dendritic cells.
To confirm a physiological relevance of the finding, we further assess the impact of motif siRNA transfection in DNA virus-mediated innate immune response in primary immature dendritic cells (iDCs). iDCs cells were transfected with different amounts of 3'm-siRNA and then cells were infected with HSV-1 at a MOI of 5. The cells were collected to measure IFNL1, IFNL2/3, IFNB, CXCL10, RANTES and TNFA mRNA expression. The results consistently showed that motif siRNA doesdependently inhibited HSV-1-mediated not only IFNL1, IFNL2/3, IFNB, but also inflammatory cytokines, CXCL10, RANTES and IFNA ( Figure 6A , 6B, 6C, 6D, 6E and 6F respectively). Therefore, the results from human primary cells further emphasized that an insight of motif siRNA as a potent therapeutic reagent to regulate auto immune diseases.
Motif siRNA specifically interrupts the binding of DNA to IFI16.
To dissect the inhibitory effect of siRNA containing the motif at 3' or 5' terminus, we examined the binding affinity of the motif siRNA to a DNA sensor protein using a DNA-conjugated pull-down assay with or without a competition strategy, the experimental protocol was shown in the Figure 7A . First, we performed a DNA-conjugated pull-down assay to define if motif siRNA interrupted DNA binding to specific DNA sensor. Biotinylated-DNA conjugated streptavidin beads were incubated with cytoplasm fraction in the absence or presence of various siRNA competitors. After incubation, proteins bounded to the beads were separated on SDS-PAGE and detected by western blot. In the pull-down assay, we added 10X higher amount of Ctrl-siRNA, mm-siRNA or 3'm-siRNA as a competitor. The results indicated that DNA binding to DNA sensor IFI16 was not interrupted when Ctrl-siRNA or mm-siRNA was added as a competitor. However, we found that the band of IFI16 was diminished in the presence of the competitor, 3'm-siRNA ( Figure 7B ). Therefore 3'm-siRNA interrupts the binding of DNA to IFI16.
To elucidate whether the interruption by 3'm-siRNA is unique to IFI16, the same pull-down assay was performed using cytosol fraction from THP-1 cells which contains multiple DNA sensors including cGAS and Ku 70 and the bounded proteins were detected by anti-cGAS or Ku70 antibody. As shown in the Figure 7C , the data indicated that 3'm-siRNA as a competitor had no interruption with DNA binding to cGAS or Ku70. Therefore, motif siRNA with the motif at the end terminus interrupts the binding of DNA to IFI16 and has no impact on the DNA sensing of cGAS or Ku70.
To compare the binding affinity between Ctrl-siRNA and 3'm-siRNA to IFI16, we performed an AlphaScreen assay. The cell lysates from the His-tagged IFI16 overexpressed 293T cells were incubated with different concentrations of 5'-biotinylated Ctrl-siRNA or 3'm-siRNA. The resulting florescence signal correlates with the number and proximity of interacting donor (Biotin-siRNA)acceptor (His-IFI16) pairs. The concentration of indicated siRNAs is plotted against the Alpha Screen signal ( Figure 7D ). Dissociation constant (kd) was calculated using the Prism. There was an inverse relationship between Kd and binding affinity. The calculated results showed that both KdHi and KdLo value of Ctrl-siRNA were higher than those of 3'm-siRNA. KdHi and KdLo for Ctrl-siRNA is 1.708 and 224.9, While KdHi and KdLo for motif siRNA is 0.6613 and 136.4, respectively, suggesting that the binding affinity of motif siRNA to IFI16 is 2.5-fold greater than Ctrl-siRNA (p=0.038). The AlphaScreen assay further supported the results in the figure 7B. It was reasonable to consider that siRNA with motif at 3' or 5' terminus had a higher binding affinity to IFI16, therefore blocked IFI16 binding to invaded DNA.
It is reported that IFI16 senses DNA and then induce phosphorylation of STING [5] . Therefore, we further assessed whether the downstream signaling of IFI16 is inhibited by 3'm-siRNA. We transfected THP-1 cells with different siRNAs, Ctrl-siRNA, 3'm-siRNA or mm-siRNA. And then the cells were further stimulated by DNA transfection. The whole cell lysate was collected at 1h after DNA transfection. Western blot was performed to detect the phosphorylation of STING, an important activation marker at downstream of IFI16. The result, as shown in the figure 7E, suggested that the phosphorylation of STING was inhibited by 3'm-siRNA, but not by mm-siRNA or Ctrl-siRNA. This result consisted with that 3'm-siRNA interrupts the binding of DNA to IFI16, and therefore inhibiting the downstream signaling for IFN response.
Discussion
siRNA was thought too short to stimulate innate immunity. However, several groups found that siRNAs can induce type I IFN through various RNA sensors, RIG-1, PKR, TLR3 and TLR7/8 in human primary cells and many human cell lines [33, [46] [47] [48] [49] [50] . We have previously reported that siRNA transfection enhances DNA-induced IFN-λ1 (type-III IFN) induction in human cells and found that the augmentation was caused by a cross talk between RIG-I and IFI16 [21] . In the current study, we provided a novel function of siRNAs: siRNA containing a 5-nt motif sequence AAGAA at either 3' or 5' terminus (3'm or 5'm-siRNA) acts as a quencher for IFI16-mediated IFNs and inflammatory cytokines.
Among screened 48 siRNA in this study, we found three siRNAs suppressed DNA-induced innate immune response. The results indicated that the inhibition was not mediated by the product of the siRNA-targeting gene, instead, the inhibition may be caused in a siRNA sequence dependent manner. We compared sequence similarity among those three siRNAs, and then we found a 5-nt sequence commonly existed in all three siRNAs. This AAGAA sequence was essential for inhibitory activity of motif siRNA, since with any one nucleotide change decreased the immunosuppressive that siRNA can induce robust IFN-α in pDC with siRNA sequence dependent manner. They defined the motif 5′-GUCCUUCAA-3′ responsible for IFN-α induction [42] . Several years ago, Zheng and his colleagues demonstrated that a group of highly effective siRNAs targeting different influenza virus H5N1 strain shares a unique motif, 5'-GGAGU-3' and demonstrated that the structure of the unique motif is critical in determining the potency of the siRNA-mediated inhibition against viral infection. And using a mouse model, they demonstrated that the viral suppression is associated with early productions of β-defensin and IL-6 production by the motif siRNA [53] . In our current study, we found that the motif 5'-AAGAA-3' negatively regulated type III IFN induction in human cells. The immunosuppressive motif sequence is distinct from all the reported motifs so far.
Further characterization clarified that the suppression effect of motif siRNA depends on the location of the motif. We designed several motif siRNAs located at different location from 5' terminus to 3' terminus. the screening suggested that the 5-nt motif must be located at 3' or 5' terminus, and then the motif siRNA has the capability to inhibit DNA-mediated signaling. The suppressing effect of the motif is completely diminished when the motif sequence in the middle of siRNA. A precise mechanism related with the location of motif remains unclear. An RNA structure analysis of the motif siRNA, as shown in the Figure EV1 , indicated that mm-siRNA forms a round closed structure, this may make mm-siRNA difficult to access the binding site of DNA sensor IFI16. By contrast, 3'm-or 5'm-siRNA possesses a stem-loop structure with the motif sequence close to the open end, suggesting that all those structures may provide a certain flexibility for motif siRNA binding to IFI16. Even Ctrl-siRNA has a similar folding structure with that of 3'm-siRNA, but this siRNA doesn't contain motif sequence, indicating that motif sequence itself makes a difference in binding affinity of the siRNA to IFI16, it may be caused in a sequence dependent fashion. Further study regarding the modeling of motif siRNA binding to DNA sensor IFI16 may provide more valuable insights.
For the function of the motif siRNA, we further confirmed that motif siRNA inhibited not only DNAinduced type III interferon response but also the production of IFNα, IFNβ and inflammatory cytokines, ORF52, an abundant gamma herpesvirus-specific tegument protein, subverts cytosolic DNA sensing by directly inhibiting cGAS enzymatic activity. They revealed a mechanism through which gamma herpesviruses antagonize host cGAS DNA sensing [57] . In another way, our finding in the current study validated a new function of siRNA with a unique 5-nt motif potently inhibits IFI16-mediated innate immune IFNs and proinflammatory cytokines in response to DNA or DNA virus invasion.
Several arguments led us to believe that these observations may have clinical implications. To further clarify what agonist-mediated innate immune response will be potentially inhibited by motif siRNAs, we established a cell culture model using THP1-Lucia ISG cells, which is derived from THP-1 cells, and has most of reported DNA sensor proteins except DAI [58] . We defined that motif siRNA suppressed DNA-plasmid, DNA together with immunostimulatory siRNA, Poly(A:T), VACV-70 and HSV-60 mediated signaling, but not 2'3'-cGAMP-mediated innate immune response. This result led us speculated that motif siRNA may inhibit the step of DNA binding to DNA sensors. 2'3'-cGAMP is produced in mammalian cells by cGAS in response to double-stranded DNA in the cytoplasm, serves as a second messenger to activate innate immune responses by binding to STING and subsequently inducing the TBK1-IRF3-dependent production of IFN-β [11] . So, we believe motif siRNA is not targeting to inhibit the downstream signaling of DNA sensors. We further validated that motif siRNA does-dependently dampened down HSV-1, a DNA virus, mediated innate immune response, but not SeV virus, an RNA virus. Taken together, the motif siRNA only inhibited DNA or DNA-virus mediated innate immune response and has no effect on RNA virus-mediated signaling transduction.
Further DNA pull-down assay and AlphaScreen analysis revealed that motif siRNA competes binding to DNA sensor IFI16, therefore it interrupts the binding of DNA or DNA virus to IFI16. This interruption is specific for IFI16. Using the similar strategy, motif siRNA cannot compete bind with Ku70 or cGAS in THP-1 cells. Taken together, those results suggest that motif siRNA only suppress IFI16-mediated innate immune response to intracellular DNA or DNA virus stimulation. The motif siRNA has a 2.5 folds stronger binding affinity to IFI16 than Ctrl-siRNA. Wu jian-jun and his colleagues reported that ORF52, a protein in KSHV, antagonize host cGAS DNA sensing [57] . Similar as their study, we found, siRNA containing a 5-nt motif antagonize host IFI16 DNA sensing, another important DNA sensor protein in host pathogen pattern recognition. In order to clarify whether the motif siRNA makes a complex with RIG-1 and IFI16, we performed motif siRNA-conjugated pull-down assay. The result as presented in the Figure EV2 , indicated that motif siRNA (3' or 5') formed a complex with RIG-1 and IFI16, and IFI16 was not dissociated from the complex in the presence of DNA as a competitor, indicating that the persistence of the complex (RIG-1-motif siRNA-IFI16) hindered the binding of IFI16 to invaded DNA. A diagram of our findings is presented in the Figure 8 .
The sensing of self and foreign DNA is delicately regulated [59] [60] [61] , and the dysregulation of DNA sensing is associated with several human autoimmune diseases, such as systemic lupus erythematosus and Aicardi-Goutières syndrome [62, 63] . Therefore, further delineation of the mechanisms by which to regulate the over-response of host cells may facilitate the development of therapeutics to treat or prevent diseases in which this pathway is dysregulated. Taken advantage of this broad anti-inflammatory and immunomodulatory properties, we reasoned that motif siRNA may prove to be beneficial as adjunctive therapy for autoimmune diseases.
Materials and Methods
Cell culture
Human cervical cancer (HeLa), SV40 T-antigen transformed human embryonic kidney cell 293 (293T) and acute human monocytic leukemia (THP-1) cell lines were obtained from American Type Culture Collection (ATCC) and maintained following manufacturer's instructions. And THP1-Lucia ISG cells were purchased from InvivoGene (San Diego, CA) and maintained following the manufacturer's protocol. To obtain human monocyte-derived immature dendritic cells (iDC), CD14+ monocytes were isolated from peripheral blood mononuclear cells (PBMCs) of healthy donors as previously described [21] , and monocytes were cultured at 0.5 x 10 6 cells/ml in RPMI1640 (Thermo Fisher Scientific, Waltham, MA ) containing 10% fetal bovine serum (GE Healthcare, Pittsburgh, PA); 50 ng/ml Granulocyte-macrophage colony-stimulating factor (R&D Systems, Minneapolis, MN ); 50 ng/ml IL-4 (R&D Systems); 25 mM HEPES (Quality Biology, Gaithersburg, MD ) and 5 µg/ml Gentamicin (Thermo Fisher Scientific) for 7 days. Non-adherent cells were harvested as iDCs for use in the subsequent experiments.
siRNAs
All siRNAs were chemically synthesized by Thermo Fisher Scientific or Integrated DNA Technologies (Coralville, IA).
Plasmids
The pCR2.1 vector (Thermo Fisher Scientific) was digested by EcoR I (NEB, Ipswich, MA) and purified. This linearized plasmid was used to stimulate cells by transfection. The His-tagged IFI16 expression vector was constructed as previously described [21] . 
Viruses and virus Infection
RNA extraction and real-time RT-PCR
Total cellular RNA was isolated from cells using the RNeasy isolation kit (Qiagen, Germantown, MD).
The cDNA was synthesized from total RNA using Taqman reverse transcription reagents (Thermo Fisher Scientific) with random hexamer primer, according to the manufacturer's instructions. IFN or inflammatory cytokine mRNA expression levels were measured using quantitative RT-PCR on a CFX96 real-time system (BioRad, Hercules, CA); the two-temperature cycle of 95 °C for 15 s and 60 °C for 1 min (repeated for 40 cycles) was used. Relative quantities of the transcript were calculated using the ΔΔCt method with GAPDH as a reference. Normalized samples were expressed relative to the average ΔCt value for controls to obtain relative fold change in expression levels. The probes specific for IFN or inflammatory cytokines were purchased from Applied Biosystems (Thermo Fisher Scientific).
Western blot
Cell lysates were prepared using RIPA buffer (Boston BioProducts, Ashland, MA) in the presence of protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO) and Halt phosphatase inhibitor cocktail (Thermo Fisher Scientific). Protein concentrations of the cell lysates were quantified using a BCA protein assay (Thermo Fisher Scientific) to ensure equal amounts of total protein were loaded in each well of NuPAGE 4-12% Bis-Tris Gel (Thermo Fisher Scientific). Proteins were transferred onto a nitrocellulose membrane and blotted with the appropriate antibodies, followed by the HRP-conjugated secondary antibodies, and the detection was performed using ECL plus Western blotting detection reagents (GE Healthcare). 
Oligonucleotide pull-down assay
AlphaScreen IFI16 and siRNA binding assay
The binding affinity of siRNA for His-tagged IFI16 was determined by an amplified luminescent proximity homogenous assay (AlphaScreen) as described [21] . Briefly, the whole cell lysate from Histagged IFI16 overexpressed HEK 293T cells was incubated with different concentration of biotinylated siRNA for 1 h at 37°C in buffer (50 mM Tris/pH7.4, 100 mM NaCl, 0.01% Tween20, 0.1% BSA) and subsequently incubated for 30 min at 25°C with Nickel Chelate acceptor beads (Perkin Elmer, Waltham, MA) and Streptavidin conjugated donor beads (Perkin Elmer). The resulting chemiluminescence emitting in the range of 520-620 nm correlates with the number and proximity of associated beads which is inversely correlated with the dissociation constant of donor (biotin-siRNA) and acceptor (His-IFI16). The assay was performed in wells of half area 96-well plates (Perkin Elmer).
Plates were analyzed for emitted fluorescence with a multilabel reader Envision (Perkin Elmer).
Microarray
RNA was quantitated and qualified with Nanodrop 1000 (Thermo Fisher Scientific) and Agilent Bioanalyzer RNA Nano 6000 chip (Agilent, Santa Clara, CA). cRNA synthesis, labeling and hybridization to the Human GeneArray (Thermo Fisher Scientific) were performed according to the manufacturer's protocol. Genechip data analysis was performed using Partek Genomics Suite (Partek, Inc., St Louis, MO). Briefly, Raw expression values for each array were normalized using a quantile normalization procedure. And the significant differences in expression were determined by one-way ANOVA. Functional enrichment analysis was performed using the DAVID (the database for annotation, visualization and integrated discovery) bioinformatics resources (https://david.ncifcrf.gov/home.jsp).
Statistical analysis
Results were representative of at least three independent experiments. The values were expressed as mean and SD of individual samples. Statistical significance was determined by the Student's t test.
A P < 0.05 was considered a significant difference between the experimental groups. Table legends   Table EV1 . The sequences (sense strand) of the immunostimulatory siRNAs which enhance DNA-mediated IFNL1 signaling. Table EV2 . The details of genes in the set of 51 that belong to each class are listed. Figure EV1 . an RNA secondary structure analysis for motif siRNAs with motif sequence at different location. RNAfold tool in ViennaRNA Web Services (http://rna.tbi.univie.ac.at/cgibin/RNAWebSuite/RNAfold.cgi) was used for RNA secondary structure prediction. 
Figure legends
Expanded view Figure and
